Free Trial

Elevation Oncology (ELEV) Institutional Ownership

Elevation Oncology logo
$0.58 0.00 (0.00%)
(As of 11/20/2024 ET)

Institutional Ownership Changes (13F Filings) for Elevation Oncology (NASDAQ:ELEV)

Current
Institutional Ownership
Percentage
83.70%
Number of
Institutional Buyers
(last 12 months)
17
Total
Institutional Inflows
(last 12 months)
$67.80M
Number of
Institutional Sellers
(last 12 months)
7
Total
Institutional Outflows
(last 12 months)
$14.29M
Get ELEV Insider Trade Alerts

Want to know when executives and insiders are buying or selling Elevation Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ELEV Institutional Buying and Selling by Quarter

Elevation Oncology Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2024 Barclays PLC72,077$43K0.0%+302.4%0.122%
11/16/2024 Geode Capital Management LLC1,110,085$666K0.0%+7.6%1.878%
11/15/2024 Frazier Life Sciences Management L.P.5,993,579$3.60M0.1%+102.6%10.138%
11/15/2024 Barclays PLC72,077$43K0.0%+302.4%0.122%
11/15/2024 Sphera Funds Management LTD.1,079,762$648K0.1%+227.2%1.826%
11/15/2024 State Street Corp1,018,026$611K0.0%+13.5%1.722%
11/14/2024 Braidwell LP473,503$284K0.0%-80.9%0.801%
11/5/2024 GSA Capital Partners LLP433,545$260K0.0%N/A0.733%
10/3/2024 SG Americas Securities LLC45,907$28K0.0%N/A0.084%
8/19/2024 Point72 Asset Management L.P.1,680,230$4.54M0.0%-50.1%3.075%
8/16/2024 Frazier Life Sciences Management L.P.2,958,579$7.99M0.4%N/A5.415%
8/15/2024 Darwin Global Management Ltd.1,916,290$4.81M0.6%-17.9%3.507%
8/15/2024 Affinity Asset Advisors LLC1,468,825$3.97M0.5%+15.8%2.688%
8/14/2024 Marshall Wace LLP37,738$102K0.0%-71.6%0.069%
8/14/2024 Logos Global Management LP3,850,000$10.40M0.8%+285.0%7.046%
8/14/2024 Farallon Capital Management LLC3,598,418$9.72M0.0%-7.4%6.586%
8/12/2024 XTX Topco Ltd38,179$103K0.0%N/A0.070%
8/8/2024 American Century Companies Inc.49,222$133K0.0%+55.7%0.090%
8/1/2024 Rhumbline Advisers64,910$175K0.0%N/A0.119%
7/26/2024 Bank of New York Mellon Corp153,586$415K0.0%N/A0.281%
5/24/2024 Farallon Capital Management LLC3,886,663$19.94M0.1%N/A7.113%
5/17/2024 Artal Group S.A.1,513,015$7.76M0.2%N/A2.769%
5/17/2024 Ikarian Capital LLC148,089$760K0.1%-87.4%0.271%
5/15/2024 venBio Partners LLC2,696,133$13.83M4.9%-7.5%4.934%
5/15/2024 Darwin Global Management Ltd.2,332,928$11.97M1.6%N/A4.270%
5/15/2024 Affinity Asset Advisors LLC1,268,825$6.51M0.8%N/A2.322%
5/10/2024 Vanguard Group Inc.1,532,045$7.86M0.0%+30.8%2.804%
5/7/2024 SG Americas Securities LLC12,244$63K0.0%N/A0.022%
11/15/2023 Armistice Capital LLC750,000$497K0.0%-68.7%1.768%
8/15/2023 Sphera Funds Management LTD.900,000$1.37M0.2%N/A2.124%
8/15/2023 Caxton Corp21,725$33K0.1%-68.2%0.051%
8/11/2023 Velan Capital Investment Management LP497,299$756K0.7%N/A1.173%
8/11/2023 ExodusPoint Capital Management LP1,499,319$2.28M0.0%N/A6.160%
5/15/2023 Sio Capital Management LLC876,611$1.67M0.8%+143.7%3.685%
5/1/2023Virtu Financial LLC27,286$52K0.0%N/A0.115%
2/15/2023 Tang Capital Management LLC479,854$456K0.1%N/A2.059%
2/13/2023 BML Capital Management LLC39,963$38K0.0%N/A0.172%
11/14/2022 Annandale Capital LLC30,000$34K0.0%N/A0.129%
11/14/2022 Cormorant Asset Management LP1,952,032$2.21M0.2%-1.6%8.377%
8/16/2022 venBio Partners LLC1,866,339$2.61M0.7%-28.4%8.013%
Breaking News: Tesla headed to $500… (Ad)

That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.

So to claim your free digital copy today, simply follow this link and enter your email address. 
8/10/2022 Kennedy Capital Management Inc.149,893$210K0.0%+968.4%0.644%
4/26/2022 Marquette Asset Management LLC38,951$98K0.0%+332.5%0.168%
4/25/2022 Bailard Inc.23,500$59K0.0%N/A0.101%
2/18/2022 TCG Crossover Management LLC555,000$3.34M1.6%N/A2.389%
2/15/2022 Kennedy Capital Management Inc.15,485$93K0.0%N/A0.067%
2/14/2022 Boxer Capital LLC872,780$5.25M0.2%-34.9%3.758%
2/14/2022 Sio Capital Management LLC250,000$1.51M0.5%N/A1.076%
1/19/2022 Marquette Asset Management LLC9,006$54K0.0%N/A0.039%
11/16/2021 Schonfeld Strategic Advisors LLC18,044$141K0.0%-29.8%0.078%
11/16/2021 Janus Henderson Group PLC1,220,205$9.38M0.0%+18.3%5.254%
11/16/2021 Caxton Corp48,183$375K0.3%+21.7%0.207%
11/9/2021BlackRock Inc.23,837$186K0.0%N/A0.103%
8/17/2021Weiss Multi Strategy Advisers LLC15,037$204K0.0%N/A0.066%
8/17/2021 Woodline Partners LP112,431$1.53M0.0%N/A0.493%
8/17/2021 Samsara BioCapital LLC932,239$12.65M1.6%N/A4.085%
8/17/2021 Sphera Funds Management LTD.30,000$407K0.0%N/A0.131%
8/17/2021 Millennium Management LLC123,062$1.67M0.0%N/A0.539%
8/17/2021 BVF Inc. IL1,590,291$21.58M0.8%N/A6.968%
8/17/2021 Boxer Capital LLC1,341,530$18.21M0.6%N/A5.878%
8/17/2021 Caas Capital Management LP60,000$814K0.0%N/A0.263%
8/17/2021 Caxton Corp39,586$537K0.4%N/A0.173%
8/16/2021 LMR Partners LLP31,300$425K0.0%N/A0.137%
8/16/2021 Point72 Asset Management L.P.50,000$679K0.0%N/A0.219%
8/16/2021 venBio Partners LLC2,608,167$35.39M4.2%N/A11.428%
8/16/2021 Alyeska Investment Group L.P.125,000$1.70M0.0%N/A0.548%
8/16/2021 Schonfeld Strategic Advisors LLC25,700$349K0.0%N/A0.113%
8/16/2021Pinz Capital Management LP36,400$494K0.1%N/A0.159%
8/16/2021 Maven Securities LTD16,000$204K0.0%N/A0.070%
8/16/2021 Goldman Sachs Group Inc.62,500$848K0.0%N/A0.274%
8/13/2021 Northern Trust Corp4,803$65K0.0%N/A0.021%
8/13/2021 Qube Research & Technologies Ltd24,255$329K0.0%N/A0.106%
8/13/2021 Vanguard Group Inc.60,000$814K0.0%N/A0.263%
8/12/2021 Monashee Investment Management LLC140,000$1.90M0.2%N/A0.613%
8/11/2021 Ghost Tree Capital LLC100,000$1.36M0.4%N/A0.438%
(Data available from 1/1/2016 forward)

ELEV Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ELEV shares?

During the previous two years, 30 institutional investors and hedge funds held shares of Elevation Oncology. The most heavily invested institutionals were venBio Partners LLC ($13.83M), Logos Global Management LP ($10.40M), Farallon Capital Management LLC ($9.72M), Vanguard Group Inc. ($7.86M), Artal Group S.A. ($7.76M), Darwin Global Management Ltd. ($4.81M), and Point72 Asset Management L.P. ($4.54M).Learn more on ELEV's institutional investors.

What percentage of Elevation Oncology stock is owned by institutional investors?

83.70% of Elevation Oncology stock is owned by institutional investors. Learn more on ELEV's institutional investor holdings.

Which institutional investors have been buying Elevation Oncology stock?

Of the 23 institutional investors that purchased Elevation Oncology stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Frazier Life Sciences Management L.P. ($5.99M), Farallon Capital Management LLC ($3.89M), Logos Global Management LP ($2.85M), Darwin Global Management Ltd. ($2.33M), Sphera Funds Management LTD. ($1.65M), Artal Group S.A. ($1.51M), and ExodusPoint Capital Management LP ($1.50M).

How much institutional buying is happening at Elevation Oncology?

Institutional investors have bought a total of 24,189,981 shares in the last 24 months. This purchase volume represents approximately $73.73M in transactions.

Which Elevation Oncology major shareholders have been selling company stock?

Of the 9 institutional investors that sold Elevation Oncology stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Braidwell LP ($2.00M), Point72 Asset Management L.P. ($1.69M), Armistice Capital LLC ($1.65M), Ikarian Capital LLC ($1.02M), Darwin Global Management Ltd. ($416.64K), Farallon Capital Management LLC ($288.25K), and venBio Partners LLC ($218.12K).

How much institutional selling is happening at Elevation Oncology?

Institutional investors have sold a total of 7,426,493 shares in the last 24 months. This volume of shares sold represents approximately $15.45M in transactions.



This page (NASDAQ:ELEV) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners